DK160805C - Farmaceutisk middel til bekaempelse af anfald af sygdomme, der involverer kramper - Google Patents

Farmaceutisk middel til bekaempelse af anfald af sygdomme, der involverer kramper

Info

Publication number
DK160805C
DK160805C DK213484A DK213484A DK160805C DK 160805 C DK160805 C DK 160805C DK 213484 A DK213484 A DK 213484A DK 213484 A DK213484 A DK 213484A DK 160805 C DK160805 C DK 160805C
Authority
DK
Denmark
Prior art keywords
illnesses
pharmaceutical agent
against diseases
fight against
dimethylglycine
Prior art date
Application number
DK213484A
Other languages
English (en)
Other versions
DK213484A (da
DK213484D0 (da
DK160805B (da
Inventor
Nikolaus Seiler
Shakir Sarhan
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK213484D0 publication Critical patent/DK213484D0/da
Publication of DK213484A publication Critical patent/DK213484A/da
Publication of DK160805B publication Critical patent/DK160805B/da
Application granted granted Critical
Publication of DK160805C publication Critical patent/DK160805C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK213484A 1983-04-29 1984-04-27 Farmaceutisk middel til bekaempelse af anfald af sygdomme, der involverer kramper DK160805C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8311804 1983-04-29
GB838311804A GB8311804D0 (en) 1983-04-29 1983-04-29 Treatment of seizure disorders and pharmaceutical compositions

Publications (4)

Publication Number Publication Date
DK213484D0 DK213484D0 (da) 1984-04-27
DK213484A DK213484A (da) 1984-10-30
DK160805B DK160805B (da) 1991-04-22
DK160805C true DK160805C (da) 1991-10-07

Family

ID=10541938

Family Applications (1)

Application Number Title Priority Date Filing Date
DK213484A DK160805C (da) 1983-04-29 1984-04-27 Farmaceutisk middel til bekaempelse af anfald af sygdomme, der involverer kramper

Country Status (15)

Country Link
US (1) US4540582A (da)
EP (1) EP0124091B1 (da)
JP (1) JPS59206309A (da)
AT (1) ATE48759T1 (da)
AU (1) AU563291B2 (da)
CA (1) CA1228818A (da)
DE (1) DE3480764D1 (da)
DK (1) DK160805C (da)
GB (2) GB8311804D0 (da)
GR (1) GR81966B (da)
IE (1) IE57286B1 (da)
IL (1) IL71650A (da)
NZ (1) NZ207962A (da)
PT (1) PT78492B (da)
ZA (1) ZA843032B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0575613B1 (de) * 1992-01-10 1998-07-22 KOMISSAROVA, Irina Alexeevna Verwendung der aminosäure glycin zur herstellung von arzneimitteln mit antistress-, stressschutz- und nootroper wirkung
ID27724A (id) * 1998-05-15 2001-04-26 Warner Lambert Co Penstabil sediaan parmasi dari turunan-turunan asam gamma-aminobutira dan proses pembuatannya
US6057368A (en) * 1998-08-05 2000-05-02 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US6395783B1 (en) 2000-10-23 2002-05-28 Brookhaven Science Associates, Llc Treatment of PCP addiction and PCP addiction-related behavior
US6713497B1 (en) * 2003-03-17 2004-03-30 Brookhaven Science Associates, Llc Use of vitamin B6 to mitigate visual field defects associated with the use of GABAergic drugs in mammals
EP1781279A2 (de) * 2004-06-11 2007-05-09 Egon Tech Präparat zur prophylaxe und therapie von stresszuständen, von funktionellen und organischen störungen des nervensystems und des stoffwechsels
WO2006075011A2 (en) * 2005-01-14 2006-07-20 N.V. Organon Glycine reuptake inhibitors for treating drug and alcohol dependence
US20160151316A1 (en) * 2012-01-27 2016-06-02 Catalyst Pharmaceutical Partners Method of treating tourette's disorder with gaba-aminotransferase inactivators
US10226442B2 (en) * 2017-07-10 2019-03-12 Syneurx International (Taiwan) Corp. Lithium salts of N-substituted glycine compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1111433A (en) * 1965-08-25 1968-04-24 Zoja Lab Chim Farm A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositions
US3960927A (en) * 1975-03-18 1976-06-01 Richardson-Merrell Inc. Olefinic derivatives of amino acids
FR2437834A1 (fr) * 1978-10-04 1980-04-30 Lejeune Jerome Compositions pharmaceutiques a base de l-serine ou de glycine
GB2120244B (en) * 1982-05-17 1985-05-01 Merrell Toraude & Co Aminoalkadiene derivative

Also Published As

Publication number Publication date
ZA843032B (en) 1984-11-28
EP0124091A3 (en) 1987-10-07
GB2138680B (en) 1986-05-21
IE841048L (en) 1984-10-29
US4540582A (en) 1985-09-10
NZ207962A (en) 1986-12-05
EP0124091A2 (en) 1984-11-07
AU2644384A (en) 1984-11-01
GB2138680A (en) 1984-10-31
JPH0527606B2 (da) 1993-04-21
IL71650A0 (en) 1984-07-31
IE57286B1 (en) 1992-07-15
IL71650A (en) 1988-07-31
DK213484A (da) 1984-10-30
DK213484D0 (da) 1984-04-27
GB8311804D0 (en) 1983-06-02
DE3480764D1 (de) 1990-01-25
JPS59206309A (ja) 1984-11-22
EP0124091B1 (en) 1989-12-20
CA1228818A (en) 1987-11-03
ATE48759T1 (de) 1990-01-15
PT78492A (en) 1984-05-01
DK160805B (da) 1991-04-22
AU563291B2 (en) 1987-07-02
GB8410504D0 (en) 1984-05-31
GR81966B (da) 1984-12-12
PT78492B (en) 1986-06-11

Similar Documents

Publication Publication Date Title
DE3579891D1 (de) N-((4,6-dimethoxypyrimidin-2-yl)aminocarbonyl)-3-trifluoromethylpyridin-2-sulfonamide oder salze davon, diese enthaltendes herbizides mittel und verfahren zur herstellung dieser verbindung.
MX9203263A (es) Composicion farmaceutica analgesica para administracion nasal.
DK160805C (da) Farmaceutisk middel til bekaempelse af anfald af sygdomme, der involverer kramper
DK0589893T3 (da) Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori
DK0738152T3 (da) Anvendelse af 2-hydroxy-5-phenylazobenzoesyrederivater som kemopræventive og kemoterapeutiske midler mod coloncancer
DK1100805T3 (da) Nitratsalte som lægemiddel
DK217585A (da) Farmaceutisk middel til behandling af neoplastiske sygdomstilstande
DK266883D0 (da) Middel til afbladning af planter med synergistisk virkning
RU94031161A (ru) Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов
DK0994704T3 (da) Anvendelse af GABA-analoger såsom gabapentin i fremstillingen af et medikament til behandling af inflammatoriske sygdomme
ES2195655T3 (es) Procedimiento para tratar fiebre hemorragica virica con proteina c.
ES520293A0 (es) Procedimiento para la fabricacion de un derivado de azolcarboxamida n,n-subsitutida.
ES542061A0 (es) Un procedimiento para la preparacion de (r)-4-amino-n-(1-fe-niletil)benzamida,(s)-4-amino-n-(1-feniletil)benzamida,o unasal de las mismas
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
DK162048C (da) 4-oxothiazolidin-2-yliden-acetamidderivater, fremgangsmaade til deres fremstilling samt deres anvendelse
DK1133314T3 (da) Protein C til behandling af seglcellesygdom og thalassæmi
ATE57526T1 (de) P-acylaminobenzamide.
MY116362A (en) Use of selegiline for the treatment of epileptic disorders
ES278851Y (es) Valvula de cierre perfeccionada.
BR9812265A (pt) Uso de análogos de gaba, tais como gabapentina, na fabricação de um medicamento para o tratamento de doenças inflamatórias.
TR199801887A2 (xx) Bir Na+/H+ - de�i�tiricisi inhibit�r�.
ES269732Y (es) Aspersor para riego perfeccionado.
FR2552297B3 (fr) Bati automoteur pour travaux agricoles, notamment pour le traitement des plantes hautes
ES268567Y (es) Pistola para riego perfeccionada.
ES269701Y (es) Capsula dosificadora para riego por goteo.

Legal Events

Date Code Title Description
PUP Patent expired